Mathematics Behind the Science: Replimune’s Oncolytic Immunotherapies
Replimune is advancing a novel pipeline of oncolytic immunotherapies derived from its RPx platform to address unmet needs in cancer treatment. Here’s an analysis of the mathematical models behind this promising approach.
1. Tumor-Immune Interaction Models
Oncolytic immunotherapies involve interactions between viruses, tumor cells, and the immune system. Mathematical models can predict these interactions over time to maximize tumor destruction and immune response.
Differential Equations: Ordinary differential equations (ODEs) describe population dynamics for:
- Tumor cells \((T)\)
- Oncolytic viruses \((V)\)
- Immune cells (like T-cells) \((I)\)
Example system of equations:
dT/dt = r * T * (1 - T/K) - α * V * T - β * I * T
dV/dt = p * T - d_V * V
dI/dt = s * V - d_I * I
Where parameters like \( r \) and \( K \) represent tumor growth and carrying capacity, and interaction terms like \( α \) and \( β \) define virus and immune effects on the tumor.
2. Viral Replication and Oncolysis
Oncolytic viruses replicate selectively within cancer cells, leading to cell lysis and the release of more viruses.
Viral Load Dynamics: The viral replication rate affects the release of viral particles, influencing the oncolysis rate (tumor cell death rate).
- Viral Replication: \( V(t) = V_0 e^{λt} \)
- Lysis Rate: \( dT/dt = -δ * T \)
This helps determine how quickly tumor cells are destroyed by viral action.
3. Immune Activation and Response
Oncolytic therapy aims to stimulate an immune response by releasing tumor antigens upon cell death.
Antigen Presentation and Immune Recruitment: The rate at which tumor antigens are released upon cell lysis can be represented by \( γ \).
- Immune Activation: \( dI/dt = ρ * γ * T – d_I * I \)
Immune-Mediated Cytotoxicity: Activated immune cells can target both infected and uninfected tumor cells, enhancing the treatment’s impact.
4. Optimization and Control
Mathematical optimization adjusts treatment parameters to maximize therapeutic impact.
Control Variables: Dosage of viral therapy, timing, and frequency of administration.
Objective Function: Minimize tumor size and maximize immune cell population while minimizing healthy cell impact.
Optimal Control Problem:
- Define a cost function including tumor volume, viral dosage, and immune response.
- Apply numerical optimization to determine the best treatment schedule.